323 related articles for article (PubMed ID: 33809456)
1. Molecular Alterations in Sporadic and
Lastres-Becker I; Porras G; Arribas-Blázquez M; Maestro I; Borrego-Hernández D; Boya P; Cerdán S; García-Redondo A; Martínez A; Martin-Requero Á
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809456
[TBL] [Abstract][Full Text] [Related]
2. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
Hayashi Y; Homma K; Ichijo H
Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
[TBL] [Abstract][Full Text] [Related]
3. Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms.
Pansarasa O; Bordoni M; Drufuca L; Diamanti L; Sproviero D; Trotti R; Bernuzzi S; La Salvia S; Gagliardi S; Ceroni M; Cereda C
Dis Model Mech; 2018 Mar; 11(3):. PubMed ID: 29419416
[TBL] [Abstract][Full Text] [Related]
4. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
[TBL] [Abstract][Full Text] [Related]
5. Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis.
Tokuda E; Takei YI; Ohara S; Fujiwara N; Hozumi I; Furukawa Y
Mol Neurodegener; 2019 Nov; 14(1):42. PubMed ID: 31744522
[TBL] [Abstract][Full Text] [Related]
6. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS.
Ayers JI; Diamond J; Sari A; Fromholt S; Galaleldeen A; Ostrow LW; Glass JD; Hart PJ; Borchelt DR
Acta Neuropathol; 2016 Dec; 132(6):827-840. PubMed ID: 27704280
[TBL] [Abstract][Full Text] [Related]
7. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models.
Kato S; Kato M; Abe Y; Matsumura T; Nishino T; Aoki M; Itoyama Y; Asayama K; Awaya A; Hirano A; Ohama E
Acta Neuropathol; 2005 Aug; 110(2):101-12. PubMed ID: 15983830
[TBL] [Abstract][Full Text] [Related]
8. Analysis of SOD1 mutations in a Chinese population with amyotrophic lateral sclerosis: a case-control study and literature review.
Wei Q; Zhou Q; Chen Y; Ou R; Cao B; Xu Y; Yang J; Shang HF
Sci Rep; 2017 Mar; 7():44606. PubMed ID: 28291249
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain.
Gregory JM; Livesey MR; McDade K; Selvaraj BT; Barton SK; Chandran S; Smith C
J Pathol; 2020 Jan; 250(1):67-78. PubMed ID: 31579943
[TBL] [Abstract][Full Text] [Related]
10. Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants.
Brown CA; Lally C; Kupelian V; Flanders WD
Neuroepidemiology; 2021; 55(5):342-353. PubMed ID: 34247168
[TBL] [Abstract][Full Text] [Related]
11. Increased reactive oxygen species in familial amyotrophic lateral sclerosis with mutations in SOD1.
Said Ahmed M; Hung WY; Zu JS; Hockberger P; Siddique T
J Neurol Sci; 2000 Jun; 176(2):88-94. PubMed ID: 10930589
[TBL] [Abstract][Full Text] [Related]
12. Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients.
Nikolić-Kokić A; Stević Z; Blagojević D; Davidović B; Jones DR; Spasić MB
Clin Chem Lab Med; 2006; 44(5):589-93. PubMed ID: 16681429
[TBL] [Abstract][Full Text] [Related]
13. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis.
Wicks P; Abrahams S; Papps B; Al-Chalabi A; Shaw CE; Leigh PN; Goldstein LH
J Neurol; 2009 Feb; 256(2):234-41. PubMed ID: 19252762
[TBL] [Abstract][Full Text] [Related]
14. MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.
Arosio A; Sala G; Rodriguez-Menendez V; Grana D; Gerardi F; Lunetta C; Ferrarese C; Tremolizzo L
Mol Cell Neurosci; 2016 Jul; 74():10-7. PubMed ID: 26921792
[TBL] [Abstract][Full Text] [Related]
15. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis.
Bowling AC; Schulz JB; Brown RH; Beal MF
J Neurochem; 1993 Dec; 61(6):2322-5. PubMed ID: 8245985
[TBL] [Abstract][Full Text] [Related]
16. SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study.
Battistini S; Giannini F; Greco G; Bibbò G; Ferrera L; Marini V; Causarano R; Casula M; Lando G; Patrosso MC; Caponnetto C; Origone P; Marocchi A; Del Corona A; Siciliano G; Carrera P; Mascia V; Giagheddu M; Carcassi C; Orrù S; Garrè C; Penco S
J Neurol; 2005 Jul; 252(7):782-8. PubMed ID: 15789135
[TBL] [Abstract][Full Text] [Related]
17. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
[TBL] [Abstract][Full Text] [Related]
19. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
[TBL] [Abstract][Full Text] [Related]
20. Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes.
Canosa A; Calvo A; Moglia C; Vasta R; Palumbo F; Solero L; Di Pede F; Cabras S; Arena V; Zocco G; Casale F; Brunetti M; Sbaiz L; Gallone S; Grassano M; Manera U; Pagani M; Chiò A
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2242-2250. PubMed ID: 35076740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
